BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6786280)

  • 21. The toxicology mechanism of endophytic fungus and swainsonine in locoweed.
    Wu C; Han T; Lu H; Zhao B
    Environ Toxicol Pharmacol; 2016 Oct; 47():38-46. PubMed ID: 27606974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the glycosidase inhibitors swainsonine and calystegine B2 in Weir vine (Ipomoea sp. Q6 [aff. calobra]) and correlation with toxicity.
    Molyneux RJ; McKenzie RA; O'Sullivan BM; Elbein AD
    J Nat Prod; 1995 Jun; 58(6):878-86. PubMed ID: 7673932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alkaloidal components in the poisonous plant, Ipomoea carnea (Convolvulaceae).
    Haraguchi M; Gorniak SL; Ikeda K; Minami Y; Kato A; Watson AA; Nash RJ; Molyneux RJ; Asano N
    J Agric Food Chem; 2003 Aug; 51(17):4995-5000. PubMed ID: 12903959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular turnover and secretion of lysosomal enzymes.
    Jessup W; Bodmer JL; Dean RT; Greenaway VA; Leoni P
    Biochem Soc Trans; 1984 Jun; 12(3):529-31. PubMed ID: 6428945
    [No Abstract]   [Full Text] [Related]  

  • 25. The indolizidine alkaloids, slaframine and swainsonine: contaminants in animal forages.
    Broquist HP
    Annu Rev Nutr; 1985; 5():391-409. PubMed ID: 3927948
    [No Abstract]   [Full Text] [Related]  

  • 26. Swainsonine: an inhibitor of glycoprotein processing.
    Elbein AD; Solf R; Dorling PR; Vosbeck K
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7393-7. PubMed ID: 6801650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Swainsonine, an inhibitor of glycoprotein processing, enhances mitogen induced interleukin 2 production and receptor expression in human lymphocytes.
    Bowlin TL; Sunkara PS
    Biochem Biophys Res Commun; 1988 Mar; 151(2):859-64. PubMed ID: 3126744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Swainsonine-containing plants and their relationship to endophytic fungi.
    Cook D; Gardner DR; Pfister JA
    J Agric Food Chem; 2014 Jul; 62(30):7326-34. PubMed ID: 24758700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of hybrid glycoproteins and accumulation of oligosaccharides in the brain of sheep and pigs administered swainsonine or locoweed.
    Tulsiani DR; Broquist HP; James LF; Touster O
    Arch Biochem Biophys; 1988 Aug; 264(2):607-17. PubMed ID: 3135781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition by swainsonine of the degradation of endocytosed glycoproteins in isolated rat liver parenchymal cells.
    Winkler JR; Segal HL
    J Biol Chem; 1984 Feb; 259(3):1958-62. PubMed ID: 6198327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Swainsonine is a useful tool to monitor the intracellular traffic of N-linked glycoproteins as a function of the state of enterocytic differentiation of HT-29 cells.
    Houri JJ; Ogier-Denis E; Bauvy C; Aubery M; Sapin C; Trugnan G; Codogno P
    Eur J Biochem; 1992 May; 205(3):1169-74. PubMed ID: 1577000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of swainsonine on interleukin-2 alpha chain receptor expression and proliferation of human lymphocytes.
    Myc A; DeAngelis P; Lassota P; Melamed MR; Darzynkiewicz Z
    Clin Exp Immunol; 1991 Jun; 84(3):406-10. PubMed ID: 1904326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of chemical modification on placental alpha-mannosidase.
    Khan FA; Basu D
    Indian J Biochem Biophys; 1984 Jun; 21(3):203-5. PubMed ID: 6440854
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies.
    Goss PE; Reid CL; Bailey D; Dennis JW
    Clin Cancer Res; 1997 Jul; 3(7):1077-86. PubMed ID: 9815786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathogenesis and toxicokinetics of locoweed (Astragalus and Oxytropis spp.) poisoning in livestock.
    Stegelmeier BL; James LF; Panter KE; Ralphs MH; Gardner DR; Molyneux RJ; Pfister JA
    J Nat Toxins; 1999 Feb; 8(1):35-45. PubMed ID: 10091126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycoprotein metabolism in normal and beta-mannosidase-deficient cultured goat skin fibroblasts.
    Hancock LW; Jones MZ; Dawson G
    Biochem J; 1986 Feb; 234(1):175-83. PubMed ID: 3085658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lisosomal storage disease caused by ingestion of Astragalus spp in llamas: an emergent concern.
    Marin RE; Uzal FA
    Vet Res Commun; 2024 May; ():. PubMed ID: 38758424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue and serum swainsonine concentrations in sheep ingesting Astragalus lentiginosus (locoweed).
    Stegelmeier BL; James LF; Panter KE; Molyneux RJ
    Vet Hum Toxicol; 1995 Aug; 37(4):336-9. PubMed ID: 8540223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of swainsonine on murine survival and bone marrow proliferation during cytotoxic chemotherapy.
    Oredipe OA; White SL; Grzegorzewski K; Gause BL; Cha JK; Miles VA; Olden K
    J Natl Cancer Inst; 1991 Aug; 83(16):1149-56. PubMed ID: 1909378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of swainsonine on rat liver and kidney: biochemical and morphological studies.
    Novikoff PM; Touster O; Novikoff AB; Tulsiani DP
    J Cell Biol; 1985 Aug; 101(2):339-49. PubMed ID: 3926777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.